HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[General Anesthesia with Remifentanil for Cesarean Section in a Patient with Moyamoya Disease].

Abstract
A 31-year-old primigravida diagnosed with moyamo- ya disease at age 27, underwent an urgent cesarean section at 37 weeks of gestation. At age 27 the patient had a superficial temporal artery-middle cerebral artery bypass operation, but the blood flow was not enough. Because she had serious anxiety neurosis and could not endure the strain of vaginal delivery or spi- nal anesthesia, general anesthesia was selected. Anesthesia was induced with thiopental, remifentanil and rocuronium, and was maintained with sevoflurane in air oxygen mixture before delivery. After delivery, anesthesia was maintained with propofol and remifent- anil. Hypertension caused by tracheal intubation was successfully prevented by remifentanil. The cesarean delivery was uneventful and a neonate was delivered with Apgar scores of 3 and 9 at 1 and 5 min, respec- tively. No adverse symptoms occurred. Both she and the neonate were discharged without adverse events. Remifentanil was effective for treating perioperative hypertension undergoing caesarean delivery in a patient with moyamoya disease.
Authors Hiroaki Sano, Yasuo Hori, Yoshihiro Yamama, Masami Yagi, Keiji Nakatani
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 65 Issue 10 Pg. 1040-1042 (10 2016) ISSN: 0021-4892 [Print] Japan
PMID30358284 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Remifentanil
Topics
  • Adult
  • Anesthesia, General
  • Anesthesia, Obstetrical
  • Apgar Score
  • Cesarean Section
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Hypertension
  • Infant, Newborn
  • Intubation, Intratracheal
  • Moyamoya Disease (complications)
  • Pregnancy
  • Pregnancy Complications
  • Remifentanil

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: